Literature DB >> 23637396

Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus.

Julieta Manrique1, Michael Piatak, William Lauer, Welkin Johnson, Keith Mansfield, Jeffrey Lifson, Ronald Desrosiers.   

Abstract

Vaccine/challenge experiments that utilize live attenuated strains of simian immunodeficiency virus (SIV) in monkeys may be useful for elucidating what is needed from a vaccine in order to achieve protective immunity. Derivatives of SIVmac239 and SIVmac239Δnef were constructed in which env sequences were replaced with those of the heterologous strain E543; these were then used in vaccine/challenge experiments. When challenge occurred at 22 weeks, 10 of 12 monkeys exhibited apparent sterilizing immunity despite a mismatch of Env sequences, compared to 12 of 12 monkeys with apparent sterilizing immunity when challenge virus was matched in its Env sequence. However, when challenge occurred at 6 weeks, 6 of 6 SIV239Δnef-immunized monkeys became superinfected by challenge virus mismatched in its Env sequence (SIV239/EnvE543). These results contrast markedly not only with the results of the week 22 challenge but also with the sterilizing immunity observed in 5 of 5 SIV239Δnef-immunized rhesus monkeys challenged at 5 weeks with SIV239, i.e., with no mismatch of Env sequences. We conclude from these studies that a mismatch of Env sequences in the challenge virus can have a dramatic effect on the extent of apparent sterilizing immunity when challenge occurs relatively early, 5 to 6 weeks after the nef-deleted SIV administration. However, by 22 weeks, mismatch of Env sequences has little or no influence on the degree of protection against challenge virus. Our findings suggest that anti-Env immune responses are a key component of the protective immunity elicited by live attenuated, nef-deleted SIV.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23637396      PMCID: PMC3700272          DOI: 10.1128/JVI.00798-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.

Authors:  D A Regier; R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1990-11       Impact factor: 2.205

3.  Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

Authors:  H Kestler; T Kodama; D Ringler; M Marthas; N Pedersen; A Lackner; D Regier; P Sehgal; M Daniel; N King
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

4.  Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

Authors:  K S Cole; J L Rowles; B A Jagerski; M Murphey-Corb; T Unangst; J E Clements; J Robinson; M S Wyand; R C Desrosiers; R C Montelaro
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.

Authors:  I Ourmanov; C R Brown; B Moss; M Carroll; L Wyatt; L Pletneva; S Goldstein; D Venzon; V M Hirsch
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3.

Authors:  V Hirsch; D Adger-Johnson; B Campbell; S Goldstein; C Brown; W R Elkins; D C Montefiori
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Titration and characterization of two rhesus-derived SIVmac challenge stocks.

Authors:  M G Lewis; S Bellah; K McKinnon; J Yalley-Ogunro; P M Zack; W R Elkins; R C Desrosiers; G A Eddy
Journal:  AIDS Res Hum Retroviruses       Date:  1994-02       Impact factor: 2.205

8.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

Authors:  M D Daniel; F Kirchhoff; S C Czajak; P K Sehgal; R C Desrosiers
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

9.  Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.

Authors:  D P Burns; C Collignon; R C Desrosiers
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines.

Authors:  Yoshinori Fukazawa; Haesun Park; Mark J Cameron; Francois Lefebvre; Richard Lum; Noel Coombes; Eisa Mahyari; Shoko I Hagen; Jin Young Bae; Marcelo Delos Reyes; Tonya Swanson; Alfred W Legasse; Andrew Sylwester; Scott G Hansen; Andrew T Smith; Petra Stafova; Rebecca Shoemaker; Yuan Li; Kelli Oswald; Michael K Axthelm; Adrian McDermott; Guido Ferrari; David C Montefiori; Paul T Edlefsen; Michael Piatak; Jeffrey D Lifson; Rafick P Sékaly; Louis J Picker
Journal:  Nat Med       Date:  2012-09-09       Impact factor: 53.440

View more
  16 in total

Review 1.  The high cost of fidelity.

Authors:  Sarah B Lloyd; Stephen J Kent; Wendy R Winnall
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01       Impact factor: 2.205

2.  Polymorphisms in Rhesus Macaque Tetherin Are Associated with Differences in Acute Viremia in Simian Immunodeficiency Virus Δnef-Infected Animals.

Authors:  Sanath Kumar Janaka; Aidin Tavakoli-Tameh; William J Neidermyer; Ruth Serra-Moreno; James A Hoxie; Ronald C Desrosiers; R Paul Johnson; Jeffrey D Lifson; Steven M Wolinsky; David T Evans
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

3.  Mamu-B*17+ Rhesus Macaques Vaccinated with env, vif, and nef Manifest Early Control of SIVmac239 Replication.

Authors:  Mauricio A Martins; Damien C Tully; Núria Pedreño-Lopez; Benjamin von Bredow; Matthias G Pauthner; Young C Shin; Maoli Yuan; Noemia S Lima; David J Bean; Lucas Gonzalez-Nieto; Aline Domingues; Martin J Gutman; Helen S Maxwell; Diogo M Magnani; Michael J Ricciardi; Varian K Bailey; John D Altman; Dennis R Burton; Keisuke Ejima; David B Allison; David T Evans; Eva G Rakasz; Christopher L Parks; Myrna C Bonaldo; Saverio Capuano; Jeffrey D Lifson; Ronald C Desrosiers; Todd M Allen; David I Watkins
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

4.  Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.

Authors:  Matthew S Sutton; Charles M Burns; Andrea M Weiler; Alexis J Balgeman; Andrew Braasch; Gabrielle Lehrer-Brey; Thomas C Friedrich; Shelby L O'Connor
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

Review 5.  Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.

Authors:  Gregory Q Del Prete; Jeffrey D Lifson; Brandon F Keele
Journal:  Curr Opin HIV AIDS       Date:  2016-11       Impact factor: 4.283

6.  The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in Mamu-B*08+ Rhesus Macaques.

Authors:  Mauricio A Martins; Lucas Gonzalez-Nieto; Young C Shin; Aline Domingues; Martin J Gutman; Helen S Maxwell; Diogo M Magnani; Michael J Ricciardi; Núria Pedreño-Lopez; Varian K Bailey; John D Altman; Christopher L Parks; David B Allison; Keisuke Ejima; Eva G Rakasz; Saverio Capuano; Ronald C Desrosiers; Jeffrey D Lifson; David I Watkins
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

7.  Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.

Authors:  Katie M Kilgore; Megan K Murphy; Samantha L Burton; Katherine S Wetzel; S Abigail Smith; Peng Xiao; Sharmila Reddy; Nicholas Francella; Donald L Sodora; Guido Silvestri; Kelly S Cole; Francois Villinger; James E Robinson; Bali Pulendran; Eric Hunter; Ronald G Collman; Rama R Amara; Cynthia A Derdeyn
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

8.  Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.

Authors:  Mauricio A Martins; Lucas Gonzalez-Nieto; Michael J Ricciardi; Varian K Bailey; Christine M Dang; Georg F Bischof; Nuria Pedreño-Lopez; Matthias G Pauthner; Dennis R Burton; Christopher L Parks; Patricia Earl; Bernard Moss; Eva G Rakasz; Jeffrey D Lifson; Ronald C Desrosiers; David I Watkins
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

9.  VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.

Authors:  Reinhard Tober; Zoltan Banki; Lisa Egerer; Alexander Muik; Sandra Behmüller; Florian Kreppel; Ute Greczmiel; Annette Oxenius; Dorothee von Laer; Janine Kimpel
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

10.  Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.

Authors:  Isabelle M Castro; Michael J Ricciardi; Lucas Gonzalez-Nieto; Eva G Rakasz; Jeffrey D Lifson; Ronald C Desrosiers; David I Watkins; Mauricio A Martins
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.